Harnessing the Healthy Gut Microbiota to Cure Patients With Recurrent C. Difficile Infection
Primary Purpose
Clostridium Difficile Infection
Status
Terminated
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
"synthetic stool" or pure cultures of probiotic intestinal bacteria
Sponsored by
About this trial
This is an interventional treatment trial for Clostridium Difficile Infection focused on measuring Clostridium difficile, recurrent, infection
Eligibility Criteria
Inclusion Criteria:
- patients with recurrent CDI that have failed standard therapy
Exclusion Criteria:
- critically ill patients
Sites / Locations
- Kingston General Hospital
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
synthetic stool
Arm Description
"synthetic stool" or pure cultures of probiotic intestinal bacteria from healthy donor stool that can be used as an enema to replace the use of stool transplant, for treatment of recurrent and refractory CDI
Outcomes
Primary Outcome Measures
number of participants cured of CDI
Secondary Outcome Measures
Full Information
NCT ID
NCT01372943
First Posted
June 8, 2011
Last Updated
November 15, 2018
Sponsor
Queen's University
Collaborators
The Physicians' Services Incorporated Foundation
1. Study Identification
Unique Protocol Identification Number
NCT01372943
Brief Title
Harnessing the Healthy Gut Microbiota to Cure Patients With Recurrent C. Difficile Infection
Official Title
A Study Using "Synthetic Stool" or Pure Cultures of Probiotic Intestinal Bacteria From Healthy Donor Stool That Can be Used as an Enema to Replace the Use of Stool Transplant, for Treatment of Recurrent and Refractory CDI
Study Type
Interventional
2. Study Status
Record Verification Date
November 2018
Overall Recruitment Status
Terminated
Why Stopped
Research priorities and focus have shifted
Study Start Date
January 2010 (undefined)
Primary Completion Date
January 2017 (Actual)
Study Completion Date
August 31, 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Queen's University
Collaborators
The Physicians' Services Incorporated Foundation
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
CDI (Clostridium difficile infection) causes diarrheal illness and can cause colitis which may be fatal. A patient being treated for CDI has a 10-25% chance of developing relapse. Recurrent CDI is on the rise. There are few options available to treat recurrent CDI. "Stool transplant" (infusing donor stool into the intestine of the recipient), is not very palatable to either patient or medical personnel. The investigators will isolate intestinal bacteria from donor stool and use this purified mixture of donor bacteria instead of stool transplant. The investigators hypothesize that this cleaner mixture of purely isolated intestinal bacteria from a healthy donor would be equally effective as conventional fecal bacteriotherapy, which uses donor stool. The use of this prepared mixture of aerobic and anaerobic organisms, or probiotic approach, is based on the same principle of fecal flora reconstitution. However our approach would provide a more controlled, reproducible, cleaner and more aesthetically acceptable method of administration, and from a patient safety perspective, would also be a safer strategy than using freshly defecated donor fecal matter.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Clostridium Difficile Infection
Keywords
Clostridium difficile, recurrent, infection
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
4 (Actual)
8. Arms, Groups, and Interventions
Arm Title
synthetic stool
Arm Type
Experimental
Arm Description
"synthetic stool" or pure cultures of probiotic intestinal bacteria from healthy donor stool that can be used as an enema to replace the use of stool transplant, for treatment of recurrent and refractory CDI
Intervention Type
Biological
Intervention Name(s)
"synthetic stool" or pure cultures of probiotic intestinal bacteria
Intervention Description
"synthetic stool" or pure cultures of probiotic intestinal bacteria from healthy donor stool that can be used as an enema to replace the use of stool transplant, for treatment of recurrent and refractory CDI
Primary Outcome Measure Information:
Title
number of participants cured of CDI
Time Frame
6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
patients with recurrent CDI that have failed standard therapy
Exclusion Criteria:
critically ill patients
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Elaine Petrof, MD
Organizational Affiliation
Queen's University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Kingston General Hospital
City
Kingston
State/Province
Ontario
ZIP/Postal Code
K7L 2V7
Country
Canada
12. IPD Sharing Statement
Citations:
PubMed Identifier
24467987
Citation
Petrof EO, Gloor GB, Vanner SJ, Weese SJ, Carter D, Daigneault MC, Brown EM, Schroeter K, Allen-Vercoe E. Stool substitute transplant therapy for the eradication of Clostridium difficile infection: 'RePOOPulating' the gut. Microbiome. 2013 Jan 9;1(1):3. doi: 10.1186/2049-2618-1-3.
Results Reference
derived
Learn more about this trial
Harnessing the Healthy Gut Microbiota to Cure Patients With Recurrent C. Difficile Infection
We'll reach out to this number within 24 hrs